← Eichor
Condition: Ldl C Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Ldl C

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Improving LDL-C Levels Through Temporal Self-regulation Theory-based, Personality-tailored Health Messages
NA · 1 location(s) · National University Health System, Singapore · NCT07415109Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Establish
Phase 3 · 95 location(s) · Novartis Pharmaceuticals · NCT06813911A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Particip
Phase 1 · 6 location(s) · AstraZeneca · NCT06980428Impact of the Corrie Lipids Digital Health Program on Lipid Optimization
NA · 1 location(s) · Johns Hopkins University · NCT07478887LDL Cholesterol TARGETs in OLDer Patients (Age≥75 Years) With ASCVD (TARGET OLD)
NA · 1 location(s) · China National Center for Cardiovascular Diseases · NCT05765370Low-carbohydrate Diet and Low-Density Lipoprotein - Cholesterol (LDL-c) Interindividual Variability
NA · 1 location(s) · University of Bath · NCT07675603Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a
NA · 1 location(s) · Duke University · NCT06471036A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Phase 1 · 2 location(s) · Monash University · NCT07428473A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEa
NA · 1 location(s) · Intermountain Health Care, Inc. · NCT06571162Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-El
NA · 2 location(s) · Sin Gon Kim · NCT07359105Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterole
Phase 3 · 19 location(s) · Novartis Pharmaceuticals · NCT06597006Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis
Phase 2 · 1 location(s) · Chang Gung Memorial Hospital · NCT07307989Atlantic Lipid Lowering Treatment Optimization Program
NA · 2 location(s) · Atlantic Health System · NCT06439654Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherap
Phase 4 · 1 location(s) · Dr. Md. Alimur Reza · NCT06789432LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering
Phase 4 · 1 location(s) · University of California, San Diego · NCT06865885Effect of the Intelligent Lipid Management Decision-support System on 1-year LDL-C Target Achievement in Ischemic Stroke
NA · 1 location(s) · Beijing Tiantan Hospital · NCT07143149Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dy
Phase 4 · 1 location(s) · Novartis Pharmaceuticals · NCT07034690Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Phase 3 · 66 location(s) · Novartis Pharmaceuticals · NCT06597019LATAM LOWERS LDL-C
Phase 4 · 11 location(s) · Novartis Pharmaceuticals · NCT06501443Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronar
Phase 3 · 63 location(s) · Novartis Pharmaceuticals · NCT07102628A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemi
Phase 2 · 34 location(s) · Regeneron Pharmaceuticals · NCT07477704A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
Phase 3 · 18 location(s) · Hasten Biopharmaceutical Co., Ltd. · NCT06568471
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.